|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.4 CHF | -0.84% |
|
-3.04% | -3.16% |
| Feb. 16 | BB Biotech's Loss Narrows in FY23; Operating Income Down | MT |
| Feb. 14 | BB Biotech AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
BB Biotech AG reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported revenue was CHF 0.649 million compared to CHF 0.723 million a year ago. Net loss was CHF 253.86 million compared to CHF 299.86 million a year ago.
Basic loss per share from continuing operations was CHF 4.63 compared to CHF 5.43 a year ago. Diluted loss per share from continuing operations was CHF 4.63 compared to CHF 5.43 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.16% | 2.5B | |
| -1.42% | 41.52B | |
| +42.15% | 39.9B | |
| +1.97% | 38.83B | |
| -14.19% | 26.05B | |
| +1.82% | 23.78B | |
| -24.55% | 18.26B | |
| -4.07% | 11.65B | |
| +21.36% | 11.53B | |
| +8.20% | 11.2B |
BB BIOTECH AG 
